1. Academic Validation
  2. Enzymatic formation of glidobactamine: a peptide nucleus of glidobactins A, B and C, new lipopeptide antitumor antibiotics

Enzymatic formation of glidobactamine: a peptide nucleus of glidobactins A, B and C, new lipopeptide antitumor antibiotics

  • J Antibiot (Tokyo). 1988 Oct;41(10):1351-7. doi: 10.7164/antibiotics.41.1351.
K Numata 1 M Oka Y Nakakita T Murakami T Miyaki M Konishi T Oki H Kawaguchi
Affiliations

Affiliation

  • 1 Bristol-Myers Research Institute, Ltd., Tokyo Research Center, Japan.
Abstract

Glidobactin deacylating activity was found in a Bacterial strain of Pseudomonas sp. Glidobactamine, a key intermediate for acyl analogues of glidobactin, was isolated from the enzymatic degradation products of glidobactins after treatment using a column of fibrous active gel on which the cells of the Pseudomonas strain were immobilized. The chemical structure of glidobactamine was confirmed as the intact peptide moiety of glidobactins by chemical reformation of glidobactin A from glidobactamine and 2,4-dodecadienoic acid which is the constitutive fatty acid of glidobactin A.

Figures
Products